Medical News

RSS

DURECT commences dosing in its POSIDUR Phase III clinical trial

DURECT Corporation announced today that it has begun dosing patients in its U.S. pivotal Phase III clinical trial to evaluate POSIDUR™ (SABER™-Bupivacaine), an investigational drug, for the treatment of post-surgical pain. The pivotal trial, referred to as BESST (Bupivacaine Effectiveness and Safety in SABER Trial), is an international, multi-center, randomized, double-blind, controlled trial evaluating the safety, efficacy, effectiveness, and pharmacokinetics of POSIDUR in patients undergoing general surgical procedures.

19 Jan 2010

KCI contributes advanced wound care products for the Haiti relief effort

Kinetic Concepts, Inc. today announced its contribution of more than $2 million dollars worth of advanced wound care products to the Haiti relief effort. The in-kind donation includes KCI’s industry-leading Active Healing SolutionsTM and Therapeutic Support SystemsTM products designed to help treat complex and hard-to-heal wounds. KCI will collaborate with Surgical Implant Generation Network (SIGN) and Project Medishare to place products in the hands of medical personnel in Haiti.

19 Jan 2010

Market Advisors Research predicts potential rise in VitaminSpice's share value

VitaminSpice is pleased to announce that Market Advisors Research has begun coverage of VitaminSpice with a very favorable report and predicts a potential rise in the valuation of the shares to $1.25 based on the continuing developments of the Company's fundamentals.

19 Jan 2010

National cross country HIV testing tour in Phoenix

The AHF/Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, rolls into Phoenix, Arizona, for a testing event from 12 p.m. to 5 p.m., Tuesday, January 19th. Free testing will take place on AHF’s new, state-of-the-art ‘Testing America’ mobile HIV testing unit at the One Voice LGBT Community Center (725 West Indian Road, Phoenix, 85013).

19 Jan 2010

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders. Preclinical results suggest that delivery of the atonal gene using GenVec's innovative adenovector technology may have the potential to restore hearing and balance function.

19 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

Titan Pharmaceuticals files registration statement on Form 10 with SEC

Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").

19 Jan 2010

CBAI collaborates with Center for Stem Cell Awareness to re-sell its stem cell collection and storage services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has contracted with The Center for Stem Cell Awareness to re-sell its stem cell collection and storage services.

19 Jan 2010

Surrex Consulting launches new division created to service the Healthcare IT and EHR market

Surrex Consulting, a nationwide provider of Information Technology (IT) Staffing and Consulting Services, today announced the launch of a new division created to service the Healthcare IT and Electronic Health Records (EHR) market.

19 Jan 2010

Medpro Safety Products purchases product development rights from Visual Connections

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection systems, has purchased product development rights for a unique, fully passive Insulin Guard self-injector from Visual Connections, owned by Hooman Asbaghi. Mr. Asbaghi is the inventor of MedPro’s fully passive phlebotomy collection devices, which include two versions of a safety blood collection holder, a passive IV catheter, and a safety blood collection set.

19 Jan 2010

First Edition: January 19, 2010

All eyes appear to be watching today's special election in Massachusetts to fill the seat of the late Senator Edward Kennedy. The outcome there could have a significant impact on what happens next in Washington regarding the Democrats' health overhaul.

19 Jan 2010

Kessler Institute offers tips to avoid injury during snow shoveling

Snow shoveling doesn't have to be a pain in the neck, back or elsewhere. In fact, shoveling snow can actually be considered good exercise if done safely and correctly.

19 Jan 2010

Filmmaker conducts workshops to promote happiness and positive thinking in community

Working in conjunction with the New York City Department of Parks & Recreation, author and documentary filmmaker Lisa Cypers Kamen will be presenting her acclaimed Harvesting Happiness Workshops to seniors and at-risk youth in New York City this week.

19 Jan 2010

IB-Salut implements Picis' CareSuite high-acuity solutions at Hospital Can Misses

Picis today announced that IB-Salut regional health services in the Spanish Balearic Islands implemented Picis Critical Care Manager and PACU Manager, part of the CareSuite® family of high-acuity solutions, at Hospital Can Misses in Ibiza. In addition, they have extended the software solution at Hospital Comarcal d’Inca and Hospital General Mateu Orfila to include the recovery care areas.

19 Jan 2010

Molina Healthcare to acquire Unisys HIM business

Unisys Corporation announced today that it has signed an agreement to sell its health information management (HIM) business to Molina Healthcare, Inc. for approximately $135 million in cash.

19 Jan 2010

Stratasys signs definitive agreement with HP to manufacture 3D printers using its patented FDM technology

Stratasys, Inc., the leading manufacturer of 3D printers and 3D production systems, today announced it has signed a definitive agreement with HP for Stratasys to manufacture an HP-branded 3D printer.

19 Jan 2010

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.

19 Jan 2010

Scarab Genomics launches White Glove IS Detection Kit

Scarab Genomics has now launched the White Glove IS Detection Kit to test for the presence of transposable Insertion Sequence (IS) elements in a DNA of interest. Numerous IS elements are naturally present in the genomes of E. coli strains commonly used for protein and plasmid production, but are not present in the Scarab Genomics Clean Genome® strains.

19 Jan 2010

Molina Healthcare enters into definitive agreement to acquire HIM business of Unisys

Molina Healthcare, Inc. today announced that it has entered into a definitive agreement to acquire the Health Information Management (HIM) business of Unisys Corporation.

19 Jan 2010

Access to clean water remains an issue for victims and Haiti earthquake volunteers

Six days after the magnitude 7.0 earthquake rocked Haiti the health and sanitation situation is still less than optimal in the makeshift camps. "Access to shelter, sanitation, water, food and medical care remains extremely limited," announced Riccardo Conti on a bulletin yesterday from the International Committee of the Red Cross (ICRC's).

19 Jan 2010

Medical News

DURECT commences dosing in its POSIDUR Phase III clinical trial

KCI contributes advanced wound care products for the Haiti relief effort

Market Advisors Research predicts potential rise in VitaminSpice's share value

National cross country HIV testing tour in Phoenix

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Titan Pharmaceuticals files registration statement on Form 10 with SEC

CBAI collaborates with Center for Stem Cell Awareness to re-sell its stem cell collection and storage services

Surrex Consulting launches new division created to service the Healthcare IT and EHR market

Medpro Safety Products purchases product development rights from Visual Connections

First Edition: January 19, 2010

Kessler Institute offers tips to avoid injury during snow shoveling

Filmmaker conducts workshops to promote happiness and positive thinking in community

IB-Salut implements Picis' CareSuite high-acuity solutions at Hospital Can Misses

Molina Healthcare to acquire Unisys HIM business

Stratasys signs definitive agreement with HP to manufacture 3D printers using its patented FDM technology

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Scarab Genomics launches White Glove IS Detection Kit

Molina Healthcare enters into definitive agreement to acquire HIM business of Unisys

Access to clean water remains an issue for victims and Haiti earthquake volunteers

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News